Skip to main content

Find Clinical Trials

Home
Conditions
Coagulation Protein Disorders

Clinical trial condition

Coagulation Protein Disorders

Explore clinical trials studying Coagulation Protein Disorders. Study availability and eligibility vary by location and protocol.

793 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Coagulation Protein Disorders trial results

Completed

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A

NCT00141843

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Phoenix, Arizona, United States

Sacramento, California, United States

San Diego, California, United States

Aurora, Colorado, United States

View all 41 locations

View Trial Details

Completed

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

NCT00038935

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Not specified

View Trial Details

Completed

Study Evaluating ReFacto AF in Severe Hemophilia A

NCT00037544

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +15 more
Locations: Not specified

View Trial Details

Completed

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

NCT00092976

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Los Angeles, California, United States

New Brunswick, New Jersey, United States

Cincinnati, Ohio, United States

Hershey, Pennsylvania, United States

View Trial Details

Completed

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

NCT00581438

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations: Not specified

View Trial Details

Completed

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

NCT00037557

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Aurora, Colorado, United States

Detroit, Michigan, United States

New Brunswick, New Jersey, United States

Chapel Hill, North Carolina, United States

View Trial Details

Completed

Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

NCT00581126

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia B

NCT00093210

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

NCT00195221

Conditions: Allergic Reactions, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +10 more
Locations: Phoenix, Arizona, United States

Orange, California, United States

Atlanta, Georgia, United States

Boise, Idaho, United States

View all 38 locations

View Trial Details

Completed

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

NCT00245297

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +10 more
Locations: Center for Hematological Research, Department of Reconstructive Orthopedic Surgery Moscow, Russia

The Russian Academy of Medical Sciences, Haemophilia Center Moscow, Russia

Republic Haemophilia Center. Saint Petersburg, Russia

View Trial Details